Renal Cancer - Results from #300

International multicenter real-world REGistry for patients with metastatic renAL cell carcinoma - Meet-URO 33 study (REGAL study). June 26, 2024

Impact of Socioeconomic Status on Patient Adherence in Managing Renal Masses. June 25, 2024

Prognostic significance of absolute lymphocyte count in patients with metastatic renal cell carcinoma receiving first-line combination immunotherapies: results from the International Metastatic Renal Cell Carcinoma Database Consortium. June 25, 2024

Renal mass biopsy - a practical and clinicopathologically relevant approach to diagnosis. June 24, 2024

The impact of the location, incidence and distribution of lung metastases in primary colorectal and renal cell cancer patients on prognosis: a retrospective observational study. June 24, 2024

Integrated mendelian randomization analyses highlight AFF3 as a novel eQTL-mediated susceptibility gene in renal cancer and its potential mechanisms. June 24, 2024

Lead Decreases Bone Morphogenetic Protein-7 (BMP-7) Expression and Increases Renal Cell Carcinoma Growth in a Sex-Divergent Manner. June 21, 2024

Nivolumab in patients with advanced renal cell carcinoma in France: interim results of the observational, real-world WITNESS study. June 21, 2024

Prevalence of Dietary Modification and Supplement Use in Patients with Metastatic Renal Cell Carcinoma Receiving Systemic Therapy. June 20, 2024

Adoption of robot-assisted radical nephroureterectomy permits a minimally invasive option for management of upper tract urothelial carcinoma in geriatric patients: comparison with non-geriatric patients with intermediate-term oncologic follow-up. June 20, 2024

Unconventional mechanism of action and resistance to rapalogs in renal cancer. June 20, 2024

Kidney cancer in the Middle East and North Africa region: a 30-year analysis (1990-2019). June 18, 2024

Emerging Novel Functional Imaging and Immunotherapy in Renal Cell Carcinoma and Current Treatment Sequencing Strategies After Immunotherapy. June 18, 2024

Comprehensive analysis of signaling lymphocyte activation molecule family as a prognostic biomarker and correlation with immune infiltration in clear cell renal cell carcinoma. June 18, 2024

A 23-year bibliometric analysis of the development of global research on hereditary renal carcinoma. June 18, 2024

Epigenomic signatures of sarcomatoid differentiation to guide the treatment of renal cell carcinoma. June 17, 2024

Cross-sectional study of therapy-related expectations/concerns of patients with metastatic renal cell carcinoma and physicians in Japan. June 17, 2024

Analyses of tumor microenvironment in patients with advanced renal cell carcinoma receiving immunotherapy (Meet-URO 18 study). June 14, 2024

Cumulative Impact of Serial Partial Nephrectomy for the Treatment of Recurrent Renal Masses. June 14, 2024

Neoadjuvant toripalimab combined with axitinib in patients with locally advanced clear cell renal cell carcinoma: a single-arm, phase II trial. June 13, 2024

Page 16 of 457